Parachute Health Appoints Heather Yi As Vice President of Customer Success
Industry Veteran Joins from Brightree to Deepen Parachute’s Partnerships with HME Providers NEW YORK, June 29, 2026 /PRNewswire/ — Parachute Health,... Read more.
Telit Cinterion Powers FleetSafe.ai AI Video Telematics for Safer, Data-Driven Fleet Operations at Scale
Telit Cinterion’s NExT™ platform powers FleetSafe.ai to deliver real-time video, driver safety insights and scalable fleet operations in high-performance... Read more.
Attunio Health Unveils Infrastructure for Measurable Mental Healthcare
Clinical Intelligence Engine™ and Digital MSE™ API introduce a new intelligence layer for precision psychiatry. ATLANTA, June 29, 2026 /PRNewswire/ — As... Read more.
EVB Charging Highlights UL- and ENERGY STAR-Certified BDC-D-UL for the U.S. and North American EV Charging Market
WENZHOU, China, June 29, 2026 /PRNewswire/ — EVB Charging is highlighting its BDC-D-UL EV charger for the U.S. and North American EV charging market, underscoring... Read more.
PERFECT GAME NAMES WIN REALITY AS OFFICIAL VIRTUAL REALITY TRAINING PARTNER
Partnership Combines the Nation’s Leading Amateur Baseball Platform with the Industry’s Leading Virtual Reality Training System SANFORD, Fla., June 29,... Read more.
Rory Meleniclis Named Chief Information Officer to Lead Next Phase of Technology Transformation for Global Specialty Lines at Intact Insurance
PLYMOUTH, Minn., June 29, 2026 /PRNewswire/ — Intact Insurance is pleased to announce the appointment of Rory Meleniclis as Chief Information Officer. In this... Read more.
H.I.G. Capital Completes Acquisition of Premier Forge Group
MIAMI, June 29, 2026 /PRNewswire/ — H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $75 billion of capital under... Read more.
symplr Names Andrew Langford Chief Financial Officer
Executive brings deep experience in finance leadership, strategic transformation and M&A to help drive symplr’s next phase of AI-powered innovation... Read more.
NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
First randomized, double-blind, placebo-controlled trial to demonstrate treatment-associated reduction of TDP-43 in people living with ALS TDP-43 pathology is present... Read more.
Mantese Honigman, PC: PSERS Class Action Settlement Checks Going Unclaimed
PHILADELPHIA, June 29, 2026 /PRNewswire/ — Over $2 million in Class Action settlement checks mailed to members of Pennsylvania’s Public School Employees... Read more.